# US 2026/0083765 A1 · Compositions for supporting, optimizing and/or improving nad+ concentrations and related methods

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0083765 A1
- Document ID: US20260083765A1
- Status: Published application
- Kind: A1
- Application number: 18/891,204
- Filed: 2024-09-20
- Published: 2026-03-26
- Earliest claimed: 2024-09-20
- Assignees: Qualia Life Sciences LLC
- Applicants: Qualia Life Sciences LLC
- Inventors: Gregory Kelly
- Web page: https://patentgrep.com/patent/US20260083765A1

## CPC

- A61K 31/706: containing six-membered rings with nitrogen as a ring hetero atom
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/197: the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid (carnitine A61K31/205)
- A61K 31/4188: condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A61K 31/4415: Pyridoxine, i.e. Vitamin B6 (pyridoxal phosphate A61K31/675)
- A61K 31/455: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A61K 31/51: Thiamines, e.g. vitamin B1
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A61K 31/525: Isoalloxazines, e.g. riboflavins, vitamin B2
- A61K 31/714: Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 36/064: Saccharomycetales, e.g. baker's yeast
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A composition for supporting nicotinamide adenine dinucleotide (NAD+) concentrations in humans is provided. The composition includes a synergistically effective amount of: nicotinamide riboside, nicotinamide and nicotinic acid; at least one of thiamin (vitamin B1), riboflavin (vitamin B2), pantothenic acid (vitamin B5), pyridoxine (vitamin B6), biotin (vitamin B7), folate (vitamin B9) and cobalamin (vitamin B12); and at least one of magnesium, trans-resveratrol and caffeine. Related methods are also provided.

## Claims

### Claim 1

A composition for supporting nicotinamide adenine dinucleotide (NAD+) concentrations in humans, the composition comprising a synergistically effective amount of:
nicotinamide riboside, nicotinamide and nicotinic acid;
at least one of thiamin (vitamin B1), riboflavin (vitamin B2), pantothenic acid (vitamin B5), pyridoxine (vitamin B6), biotin (vitamin B7), folate (vitamin B9) and cobalamin (vitamin B12); and
at least one of magnesium, trans-resveratrol and caffeine.

### Claim 2 (depends on 1)

The composition of claim 1, comprising:
less than 30 mg of nicotinic acid;
between 100-500 mg of niacinamide;
between 132-880 mg of nicotinamide riboside or between 150-1000 mg of nicotinamide riboside chloride;
between 0.16-6 mg of thiamin (vitamin B1);
between 0.2-6 mg of riboflavin (vitamin B2);
between 0.65-10 mg of pantothenic acid (vitamin B5);
between 0.24-8 mg of pyridoxine (vitamin B6);
between 0.15-30 mcg of biotin (vitamin B7);
between 50-800 mcg of folate (vitamin B9);
between 0.5-10 mcg of cobalamin (vitamin B12);
less than 50 mg of caffeine;
between 8-200 mg of trans-resveratrol; and
between 25-167 mg of magnesium.

### Claim 3 (depends on 2)

The composition of claim 2, comprising:
between 8-29 mg of nicotinic acid;
approximately 234 mg of niacinamide; and
approximately 264 mg of nicotinamide riboside or approximately 300 mg of nicotinamide riboside chloride.

### Claim 4 (depends on 2)

The composition of claim 2, comprising:
approximately 25 mg of nicotinic acid;
approximately 234 mg of niacinamide; and
approximately 264 mg of nicotinamide riboside or approximately 300 mg of nicotinamide riboside chloride.

### Claim 5 (depends on 2)

The composition of claim 2, comprising:
approximately 16 mg of nicotinic acid;
approximately 234 mg of niacinamide; and
approximately 264 mg of nicotinamide riboside or approximately 300 mg of nicotinamide riboside chloride.

### Claim 6 (depends on 2)

The composition of claim 2, comprising:
approximately 0.32 mg of thiamin (vitamin B1);
approximately 0.4 mg of riboflavin (vitamin B2);
approximately 1.375 mg of pantothenic acid (vitamin B5);
approximately 0.49 mg of pyridoxine (vitamin B6);
approximately 37.5 mcg of biotin (vitamin B7);
approximately 166 mcg DFE of folate (vitamin B9); and
approximately 1.5 mcg of cobalamin (vitamin B12).

### Claim 7 (depends on 1)

The composition of claim 1, wherein the composition comprises postbiotic yeast comprising the at least one of riboflavin (vitamin B2), pantothenic acid (vitamin B5), pyridoxine (vitamin B6), biotin (vitamin B7), folate (vitamin B9) and cobalamin (vitamin B12).

### Claim 8 (depends on 7)

The composition of claim 7, wherein the postbiotic yeast comprise Saccharomyces cerevisiae.

### Claim 9 (depends on 2)

The composition of claim 2, comprising:
approximately 28 mg of caffeine;
approximately 50 mg of trans-resveratrol; and
approximately 50 mg of magnesium.

### Claim 10 (depends on 2)

The composition of claim 2, comprising less than 40 mg of caffeine.

### Claim 11 (depends on 10)

The composition of claim 10, comprising between 10-39 mg of caffeine.

### Claim 12 (depends on 2)

composition of claim 2, wherein the composition comprises whole coffee fruit extract, which comprises the caffeine.

### Claim 13 (depends on 1)

The composition of claim 1, further disposed within at least one pharmaceutically acceptable vehicle.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the composition is a powder.

### Claim 15

A method of supporting nicotinamide adenine dinucleotide (NAD+) concentrations in humans, the method comprising:
orally administering a composition comprising a synergistically effective amount of:
nicotinamide riboside, nicotinamide and nicotinic acid;
at least one of thiamin (vitamin B1), riboflavin (vitamin B2), pantothenic acid (vitamin B5), pyridoxine (vitamin B6), biotin (vitamin B7), folate (vitamin B9) and cobalamin (vitamin B12); and
at least one of magnesium, trans-resveratrol and caffeine.

### Claim 16 (depends on 15)

method of claim 15, further comprising measuring NAD+ concentration in the body.

### Claim 17

A method of manufacturing a composition for supporting nicotinamide adenine dinucleotide (NAD+) concentrations in humans, the method comprising:
combining a synergistically effective amount of:
nicotinamide riboside, nicotinamide and nicotinic acid;
at least one of thiamin (vitamin B1), riboflavin (vitamin B2), pantothenic acid (vitamin B5), pyridoxine (vitamin B6), biotin (vitamin B7), folate (vitamin B9) and cobalamin (vitamin B12); and
at least one of magnesium, trans-resveratrol and caffeine.

### Claim 18 (depends on 17)

The method of claim 17, further comprising disposing the composition within at least one pharmaceutically acceptable vehicle.
